Disulfiram for Brain Tumor

This trial explores whether disulfiram, a drug used for other conditions, can help treat glioblastoma, an aggressive brain tumor. Researchers aim to determine if disulfiram can make the tumor environment less hostile to the immune system and reduce brain swelling before surgery. The trial seeks participants with glioblastoma who are scheduled for surgery and can begin taking disulfiram a few days prior. Participants should be ready to stay in the hospital during the study and must avoid alcohol. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants a chance to contribute to groundbreaking research.

The trial requires you to stop taking dexamethasone or other systemic glucocorticoids before enrolling. You also cannot use metronidazole or other medications that interact with disulfiram. It's best to discuss your current medications with the trial team to ensure they are not contraindicated.

Research has shown that disulfiram, a drug commonly used to treat alcoholism, is under investigation for its potential to treat brain cancer. Lab studies indicate that disulfiram can kill certain cancer cells, suggesting it might be useful for treating aggressive brain tumors like glioblastoma.

Although disulfiram has been used for a long time, its application in cancer treatment is new. The current study remains in the early stages, so researchers are still assessing its safety for treating brain tumors. Early research on disulfiram for other purposes suggests it is generally well-tolerated. However, since this study is just beginning, the main focus is on ensuring its safety for people with brain tumors.

Disulfiram is unique because it is traditionally used to treat alcohol dependence, but researchers are now exploring its potential in fighting brain tumors. Unlike standard treatments for brain tumors, which typically include surgery, radiation, and chemotherapy targeting rapidly dividing cells, Disulfiram works differently by inhibiting a specific enzyme related to tumor growth. This repurposing of a known drug offers a promising new approach, as it may offer a less invasive and potentially more targeted treatment option. Researchers are particularly excited because Disulfiram's new mechanism of action could open the door to innovative ways to tackle brain tumors.

Studies have shown that disulfiram, a drug typically used to treat alcoholism, might also help fight glioblastoma, a type of brain cancer. Lab research suggests that disulfiram can kill glioblastoma cells, especially when combined with chemotherapy. It seems to work by making the tumor environment less suitable for cancer growth. Disulfiram might also reduce the need for steroids, which often control brain swelling. Although the results are promising, more research is needed to confirm these effects in people with glioblastoma. Participants in this trial will receive disulfiram to further investigate its potential benefits for glioblastoma treatment.⁶⁷⁸⁹¹⁰